Full Text View
Tabular View
Study Results
Related Studies
Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma
This study has been terminated.
( Due to slow accrual )
Study NCT00843310   Information provided by New York University School of Medicine

First Received on February 12, 2009.   Last Updated on August 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial